Skip to main content
logo
Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.2100
-0.0001 (-0.05%)
At close: Jul 31, 2026, 4:00 PM EDT
0.2131
+0.0031 (1.48%)
After-hours: Jul 31, 2026, 8:00 PM EDT

Theriva Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.3-----
Revenue Growth
------
Gross Profit
0.3-----
Selling, General & Admin
16.0715.457.47.129.866.47
Research & Development
5.998.612.0314.3111.727.8
Other Operating Expenses
--6.92---
Total Operating Expenses
22.0624.0526.3521.4321.5814.27
Operating Income
-21.76-24.05-26.35-21.43-21.58-14.27
Interest Income
0.120.290.71.440.510.01
Other Non-Operating Income (Expense)
0.030.03-00-0.04-
Total Non-Operating Income (Expense)
0.150.310.691.440.470.01
Pretax Income
-21.61-23.74-25.65-19.99-21.11-14.27
Provision for Income Taxes
----1.64-1.43-
Net Income
-21.46-23.74-25.65-18.35-19.69-14.27
Minority Interest in Earnings
------0
Net Income Attributable to Preferred Dividends
-1.51---0.34-8.92
Net Income to Common
-22.97-25.25-25.65-18.35-20.03-23.19
Net Income Growth
------
Shares Outstanding (Basic)
22121110
Shares Outstanding (Diluted)
22121110
Shares Change
1059.27%800.56%109.24%5.09%25.76%541.06%
EPS (Basic)
-1.13-2.08-19.03-28.48-32.75-47.50
EPS (Diluted)
-1.13-2.08-19.03-28.48-32.75-47.50
EPS Growth
------
Free Cash Flow
-14.37-16.7-16.94-19.2-19.2-12.9
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.66-1.38-12.56-29.80-31.31-26.47
Gross Margin
100.00%-----
Operating Margin
-7254.00%-----
Profit Margin
-7153.00%-----
FCF Margin
-4789.67%-----
EBITDA
-21.66-23.94-26.21-21.3-21.5-14.19
EBITDA Margin
-7218.67%-----
EBIT
-21.76-24.05-26.35-21.43-21.58-14.27
EBIT Margin
-7254.00%-----
Effective Tax Rate
-0.00%0.00%8.20%6.75%0.00%
SEC Filings: 10-K · 10-Q